Metastasis is the main cause of death in cancer patients but remains a poorly understood 15 process. Small cell lung cancer (SCLC) is one of the most lethal and most metastatic types of 16 human cancer. SCLC cells normally express neuroendocrine and neuronal gene programs but 17 accumulating evidence indicates that these cancer cells become relatively more neuronal and less 18 neuroendocrine as they gain the ability to metastasize. Here we show that mouse and human 19 SCLC cells in culture and in vivo can grow cellular protrusions that resemble axons. The 20 formation of these protrusions is controlled by multiple neuronal factors implicated in 21 axonogenesis, axon guidance, and neuroblast migration. Disruption of these axon-like 22 protrusions impairs cell migration in culture and inhibits metastatic ability in vivo. The co-option 23 of developmental neuronal programs is a novel molecular and cellular mechanism that 24 contributes to the high metastatic ability of SCLC. 25 65 cells that have transitioned to a more neuronal cell state. 66 5 68 To investigate SCLC migration, we developed an assay in which SCLC cells, which 69 classically grow in culture as floating spheres or aggregates, are grown as a monolayer under 70 Matrigel ((Denny et al., 2016) and Methods). Unexpectedly, we noticed that cells from some 71 SCLC cell lines (N2N1G, 16T, 6PF) derived from the Rb f/f ;p53 f/f (DKO) and Rb f/f ;p53 f/f ;p130 f/f 72 (TKO) genetically engineered mouse models form long cellular protrusions into cell-free spaces 73 ( Figure 1A-B ). To determine whether these structures specifically project into cell-free areas or 74 they also exist within monolayers, we cultured a minor fraction of fluorescently-labeled,
INTRODUCTION
Metastases are a major cause of cancer-related morbidity and mortality. By the time cancer 27 cells leave their primary site and spread to distant sites, they have acquired the ability to migrate 28 and invade, as well as characteristics that enable them to survive and proliferate within new 29 8 protrusions was also greatly increased compared to cells that do not form protrusions 134 ( Figure S2D ). 135 Together, these results indicate that SCLC cells can generate axon-like protrusions and that 136 these projections facilitate migration in a manner that is qualitatively similar to neuroblast 137 migration during brain development. 139 To investigate the functional importance of these axon-like protrusions, we focused on 13 140 genes (out of the 69 genes selected above) that encode for proteins involved in diverse aspects of 141 axon formation, axon guidance, and neuronal migration (Table S4 ). These 13 genes are all 142 expressed in at least a subset of human SCLC tumors ( Figure S4A ) (data from (George et al., 143 2015)). We excluded gene families for which functional overlap and compensatory mechanism 144 were likely. STRING analysis and literature searches confirmed that these 13 candidates had a 145 significant connection with biological processes related to neurogenesis and the regulation of 146 neuron projection development but that the proteins were not all directly connected and thus 147 likely contribute to distinct aspects of these biological processes ( Figure S4B and Table S5 ). In 148 the 25 human SCLC cell lines analyzed in the Cancer Dependency Map project, knock-down of 149 these 13 genes rarely affected the expansion of SCLC cells in culture, consistent with these genes 150 influencing aspects of cell physiology not related to the cell cycle (Table S6 and Figure S4C -D). 151 We first knocked-down each of these genes with two shRNAs in a murine SCLC cell line 152 derived from a lymph node metastasis (N2N1G). We confirmed stable knockdown by RT-qPCR 153 (Table S7 ) and quantified the development of protrusions in the monolayer culture assay. down of 11 of the 13 genes significantly reduced the number of protrusions with at least one 155 9 shRNA ( Figure 3A-B and Figure S5A ). The observation that the knock-down of multiple factors 156 normally implicated at distinct steps of axonal growth reduces the development of the 157 protrusions from SCLC cells further bolsters the notion that these protrusions are similar to 158 neuronal axons. Knock-down of the many genes involved in axon formation, axonal guidance, 159 and neuronal migration also reduced cell migration in the same assay ( Figure 3B ). Quantification 160 of cell migration showed that inhibition of migration correlated with loss of the axon-like 161 protrusions ( Figure 3C-D) . We validated the knock-down for two of the top candidates, Gap43 162 and Fez1 genes, by immunoblot for the corresponding proteins in N2N1G cells ( Figure S5B -C). 163 We further validated the effects of knocking down these two factors on the growth of protrusions 164 and cell migration in a second SCLC cell line (16T; Figure 3E -J and Figure S5D -E). 165 Together, these data show that SCLC cells with axon-like protrusions migrate in culture 166 similar to what has been described for neuroblasts and that disruption of these protrusions by 167 knocking-down a variety of genes involved in axonogenesis and neuronal migration also affects 168 SCLC migration.
138

Loss of Axon-like protrusions inhibits the migration of SCLC cells
169
Knock-down of genes associated with the formation of protrusions results in decreased 170 metastatic potential 171 The link between axon-like protrusions and migration in vitro led us to investigate whether 172 these axon-like protrusions promote the metastatic ability of SCLC cells in vivo. In support of 173 this idea, we found that the expression of neuron-specific class III beta-tubulin and TAU was 174 barely detectable in non-metastatic tumors in the lungs of TKO mice 3 months after cancer 175 initiation while a majority of later stage tumors stained strongly positive for both proteins 176 ( Figure S6A-B ).
177
To test the role of these protrusions in the metastatic process in vivo, we investigated whether 10 SCLC cells with Gap43 or Fez1 knocked-down had reduced metastatic ability. The products of 179 these genes are thought to regulate axonal development in entirely distinct manners but knock-180 down of each reduced the formation of protrusions and cell migration in culture. We first 181 assessed whether Gap43 and Fez1 knock-down reduced the metastatic ability of mouse N2N1G 182 SCLC cells after transplanting control and knock-down cells into recipient mice and assessing 183 metastasis formation 4-5 weeks after intravenous injection. Knock-down of each of these pro-184 protrusion factors significantly reduced the number of metastases as assessed by tumor counts at 185 the surface of the liver ( Figure S7A -B). To determine whether GAP43 and FEZ1 are simply 186 required for tumor growth in vivo, we transplanted Gap43 and Fez1 knock-down cells 187 subcutaneously and quantified tumor growth. Knock-down of these genes had no effect on 188 subcutaneous tumor growth suggesting that the effects on metastatic ability likely represent the 189 disruption of phenotypes uniquely associated with the metastatic process ( Figure S7C ). We 190 repeated these experiments with two independent shRNAs for each gene in both N2N1G and 191 16T SCLC cells, which confirmed that Gap43 and Fez1 knock-down inhibits the formation of 192 liver metastases after intravenous injection of SCLC cells ( Figure 4A -H and Figure S7D -E).
193
The absence of growth defects in subcutaneous tumors following Gap43 and Fez1 knock-194 down suggested that these genes may affect earlier steps of the metastatic cascade. To test this, 195 we performed similar intravenous transplant experiments but quantified the presence of SCLC 196 cells in the liver 2 days after injection ( Figure 4I ). Quantification of GFP positive cancer cells in the 197 liver by flow cytometry documented a significant reduction in metastatic seeding by SCLC cells While metastasis remains a major cause of morbidity and mortality in SCLC patients, its 203 underlying mechanisms remain poorly understood and no therapeutic strategies exist to prevent 204 or target it. Here we investigated the function of neuronal gene expression programs in 205 metastatic SCLC. We found that SCLC cells can grow axon-like protrusions and that these 206 protrusions contribute to the migratory and metastatic phenotypes of these cells. This study 207 identifies a cellular mechanism by which a neuroendocrine-to-neuronal transition promotes 208 metastasis of SCLC cells.
209
The expression of neuronal factors in SCLC has been known for more than three decades 210 and has been used as a marker for disease progression (Carney et al., 1982 , Cutz, 1982 , Broers et 211 al., 1987 , Anderson et al., 1988 . However, whether neuronal programs in SCLC cells play a 212 direct role in SCLC progression had not been rigorously investigated. We uncovered the growth 213 of axon-like protrusions as one functional aspect of neuronal differentiation in SCLC and 214 provide data to support a role for these protrusions in migration and metastasis. It is likely that 215 other phenotypes usually associated with neurons beyond these axon-like protrusions also 216 contribute to the expansion and the spread of SCLC cells. Beyond facilitating metastatic seeding 217 to the liver, these axon-like protrusions may have other functions, including helping SCLC cells 218 migrate within the primary tumor, intravasate into the bloodstream, and move within the 219 parenchyma during metastatic expansion (Shibue et al., 2012) . Future investigation of the roles 220 of axon-like protrusions in SCLC will likely benefit from additional genetic analyses as well as 221 high-resolution in vivo imaging methods. Recent evidence suggests that several other human 222 tumor types also increase the expression of neuronal programs as they become more metastatic, 223 especially to the brain (Wingrove et al., 2019) . It will be important for future studies to 224 12 determine if aspects of the neuronal program also contribute to the striking ability of SCLC cells 225 to seed and expand in the brain (Lukas et al., 2017) . 226 Our data indicate that SCLC metastasis is facilitated by the development of axon-like 227 protrusions, but other molecular mechanisms certainly also increase the probability that a cancer 228 cell will successfully overcome all the hurdles that limit the development of tissue destructive 229 metastases. For instance, we found that knock-down of Dcx (coding for Doublecortin) has little 230 to no effect on the number of protrusions but strongly inhibits migration in our 2D Matrigel 231 assay ( Figure 3A -B), thus suggesting that Doublecortin promotes SCLC migration independent 232 from any impact of protrusion formation.
233
The formation of protrusions in SCLC cells is controlled by pathways previously implicated 234 in the formation of axons and the migration of neuronal cells but it is unclear how the expression 235 of these pro-protrusion genes is coordinated. We and others have identified a role for the NFIB 236 transcription factor in SCLC metastasis and the induction of gene programs linked with 237 axonogenesis and neuronal migration (Denny et al., 2016 , Semenova et al., 2016 2016). However, overexpression of NFIB in naturally NFIB low cell lines is not sufficient to 239 induce the growth of protrusions in SCLC cells (unpublished observations). Thus, the upstream 240 factors that control these neuronal programs in SCLC remain to be characterized. Accumulating (Guo et al., 2000) .
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Could an understanding of the molecular and cellular processes related to axon-like 251 protrusions in SCLC cells ultimately be translated into clinical benefit for SCLC patients?
252
Previous studies on SCLC have targeted the CXCR4 chemokine receptor due to its role in cell 253 adhesion and migration and its expression in SCLC cells (Burger et al., 2003 , Teicher, 2014 , 254 Taromi et al., 2016 . CXCR4 also contributes to the formation of axon-like protrusions ( Figure   255 3). In a recent clinical trial in SCLC patients, CXCR4 inhibition was well tolerated but this 256 inhibition did not significantly reduce disease progression (Salgia et al., 2017) . Mechanisms that 257 drive the ability of cancer cells to overcome early barriers of metastatic seeding will likely need 258 to be employed in specific settings where inhibition of the metastatic process would logically Silicone inserts (ibidi 80209, Grafelfing, Germany) were attached to wells in 12-well (up to two 300 inserts) or 24-well (one insert) plates pre-coated with poly-D-lysine for 15 minutes (Sigma-301 Aldrich, St. Louis, MO). ~8x10 5 cells were seeded to each chamber of the insert in 100 µL 302 resulting in cells at ~80-90% confluency. After at least 6 hours, the inserts were carefully Table S7 shows the sequences of the oligonucleotides used to knock down the candidate genes.
365
Note that the expression of the shRNAs targeting GFP partially decreased GFP expression, but 366 19 cancer cells were still GFP positive and could be well-detected by flow cytometry. A Figure S1 (related to Figure 1) A Figure 4 : Genes involved in the generation of protrusions also control the formation of metastases A. Diagram of the approach to investigate the formation of liver metastases (met.) after intravenous injection of SCLC cells. B-C. Quantification of the number of metastases 4 and 5 weeks after intravenous injection of N2N1G and 16T mSCLC cells, respectively, with control knock-down or knock-down of Gap43 with two independent shRNAs. For N2N1G, tumors at the surface of the liver were quantified on the liver surface, as shown in Supplementary Figure S7D 
